EFFECT OF MACROPHAGES ON INTERLEUKIN-2 (IL-2)-INDUCED AND IL-4-INDUCED MURINE LYMPHOKINE-ACTIVATED KILLER ACTIVITY

被引:7
|
作者
TUNRU, IS [1 ]
SUZUKI, H [1 ]
YANO, S [1 ]
机构
[1] TOYAMA MED & PHARMACEUT UNIV, DEPT INTERNAL MED 1, 2630 SUGITANI, SUGITANI, TOYAMA 93001, JAPAN
关键词
D O I
10.1002/ijc.2910480415
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The enhancing effect of macrophages on interleukin-2 (IL-2)- and IL-4-induced murine lymphokine-activated killer (LAK) activity was investigated in this study. Peritoneal macrophages significantly enhanced LAK activity generated from accessory cell-depleted splenic lymphocytes in both IL-2 and IL-4 cultures. This effect was dependent on the number of macrophages and was not replaced by a factor derived from macrophages or lymphocytes. Macrophages enhanced IL-2- and IL-4-induced LAK activity against both natural killer (NK)-sensitive (YAC-I, P388D1) and NK-resistant (P815) tumor cells. Negative selection of cells with antibodies and complement showed no differences in surface markers between IL-2 LAK effectors and IL-4 LAK effectors generated in the presence of macrophages. These results suggest that the same LAK effector subsets can be enhanced by macrophages in either IL-2 or IL-4 cultures.
引用
收藏
页码:568 / 573
页数:6
相关论文
共 50 条
  • [31] RANDOMIZED STUDY OF INTERLEUKIN 2 (IL-2) ALONE VS IL-2 PLUS LYMPHOKINE-ACTIVATED KILLER-CELLS FOR TREATMENT OF MELANOMA AND RENAL-CELL CANCER
    KORETZ, MJ
    LAWSON, DH
    YORK, RM
    GRAHAM, SD
    MURRAY, DR
    GILLESPIE, TM
    LEVITT, D
    SELL, KM
    ARCHIVES OF SURGERY, 1991, 126 (07) : 898 - 903
  • [32] EFFECT OF CORTICOSTEROID ON THE ANTITUMOR-ACTIVITY OF LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 IN MICE
    PAPA, MZ
    VETTO, JT
    ETTINGHAUSEN, SE
    MULE, JJ
    ROSENBERG, SA
    CANCER RESEARCH, 1986, 46 (11) : 5618 - 5623
  • [33] IMMUNOTHERAPY OF CANCER WITH LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2
    ROSENBERG, SA
    MULE, JJ
    SURGERY, 1985, 98 (03) : 437 - 444
  • [34] CLINICAL-RESPONSE TO INTERLEUKIN-2 (IL-2) LYMPHOKINE-ACTIVATED KILLER (LAK) THERAPY OF ADVANCED MELANOMA IN A HUMAN IMMUNODEFICIENCY VIRUS (HIV) POSITIVE PATIENT
    WALLACK, MK
    DAVILA, E
    RESNICK, L
    BUSSO, M
    GRONKA, S
    DARNELL, E
    BASH, JA
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1989, 8 (03): : 327 - 327
  • [35] INTERLEUKIN-6 DOES NOT SUPPORT INTERLEUKIN-2 INDUCED GENERATION OF HUMAN LYMPHOKINE-ACTIVATED KILLER-CELLS
    KLINGEMANN, HG
    WONG, E
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 33 (06) : 395 - 397
  • [36] Ultrastructural and functional studies of the interaction between IL-12 and IL-2 for the generation of lymphokine-activated killer cells
    Facchetti, P
    Tacchetti, C
    Prigione, I
    Airoldi, I
    Favre, A
    Grossi, CE
    Pistoia, V
    EXPERIMENTAL CELL RESEARCH, 1999, 253 (02) : 440 - 453
  • [37] INTERLEUKIN-2 (IL-2)-INDUCED TYROSINE PHOSPHORYLATION OF IL-2 RECEPTOR-P75
    ASAO, H
    TAKESHITA, T
    NAKAMURA, M
    NAGATA, K
    SUGAMURA, K
    JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (03): : 637 - 644
  • [38] CYTOTOXIC LYMPHOCYTES-T (CTL) COMPLETE WITH LYMPHOKINE ACTIVATED KILLER (LAK) CELLS FOR INTERLEUKIN-2 (IL-2) AND CAN ABROGATE THEIR EFFECT
    SUGARBAKER, PH
    EGGERMONT, AMM
    STELLER, EP
    MATTHEWS, W
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 343 - 343
  • [39] Lymphokine-activated killer cells induced in vivo in mice showing IL-2 toxicity have cytoplasmic granules containing perforin and its hemolytic activity
    Ueno, M
    IMMUNOPHARMACOLOGY, 1998, 39 (02): : 75 - 82
  • [40] CHARACTERIZATION OF LYMPHOKINE-ACTIVATED KILLING BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS STIMULATED WITH INTERLEUKIN-2 (IL-2) ANALOGS SPECIFIC FOR THE INTERMEDIATE AFFINITY IL-2 RECEPTOR
    HEATON, KM
    JU, G
    MORRIS, DK
    DELISIO, K
    BAILON, P
    GRIMM, EA
    CELLULAR IMMUNOLOGY, 1993, 147 (01) : 167 - 179